Genlabs Retatrutide 20mg (3 mL Cartridge) is a next-generation injectable medication currently under clinical investigation for the management of obesity, type 2 diabetes, and metabolic disorders. It is administered using a reusable injection pen, offering precision dosing and convenience.
Genlabs Retatrutide20mg pen is drawing major attention because it targets three metabolic hormone receptors, setting it apart from existing weight-loss and diabetes therapies.
PRESENTATION: 1 Pen + 1 3ML Cartridge
Made in Germany
Manufactured by Genlabs
STAPEL: GLRETA20C